Read more

July 22, 2023
2 min watch
Save

VIDEO: Lp(a) testing often warranted, but how to treat high levels unclear

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • High levels of lipoprotein(a) is known to be linked with CVD risk, but how to act on that information remains unclear.
  • Many patients should be tested for Lp(a) at least once in their life.

ARLINGTON, Texas — In this Healio video exclusive, an expert breaks down a session on the significance of lipoprotein(a) at the American Society for Preventive Cardiology Congress on CVD Prevention.

Sadiya S. Khan, MD, MSc, Magerstadt Professor of Cardiovascular Epidemiology and assistant professor of medicine (cardiology) and preventive medicine (epidemiology) at Northwestern University Feinberg School of Medicine, said while the harms from high Lp(a) have been known for a long time, “we still haven’t figured out who to test, what to do with that number and how to lower cardiovascular disease risk if that number is high.”

Risk for CVD related to Lp(a) is independent of CVD risk from LDL, so “testing it at least once in a lifetime may be considered,” especially in patients at borderline or intermediate CVD risk, she said.

Watch the video for more.

Reference:

  • Khan SS, et al. Session 3: Lipoprotein(a): The new(ish) kid on the block. Presented at: American Society for Preventive Cardiology Congress on CVD Prevention; July 21-23, 2023; Arlington, Texas.